-500x500.jpg "TRIOVET-F ® (solution for injection)")
TRIOVET-F ® (solution for injection)
| Ingredients: | Vitamin D (ergocalciferol or cholecalciferol), vitamin F (linetol), vitamin A (retinol acetate and palmitate), vitamin E (tocopherol acetate) |
| Application: | Injection, Oral |
| Type of formulation: | vitamins |
Description
Clear oily liquid, light yellow to dark yellow in colour, with a characteristic odour of its components.
Composition
1 ml of the product contains the following active substances:
- itamin A (retinyl acetate) — 30,000 IU;
- vitamin D3 (cholecalciferol) — 40,000 IU;
- vitamin E (α- tocopheryl acetate) — 20 mg;
- vitamin F (Linetol) — 5 mg.
Excipients: sunflower oil.
Pharmacological Properties
ATC vet classification code: QA11B Multivitamins, no additives. QA11BA Multivitamins, plain.
The action of the product is determined by the properties of vitamins A, D3, E, and F contained in its composition.
Vitamin A participates in oxidation-reduction processes and maintains the normal functioning of mucous membranes and visual organs.
Vitamin D3 exerts a positive effect on calcium and phosphorus metabolism in the body.
Vitamin E participates in the metabolism of proteins, fats, and carbohydrates, prevents the oxidation of unsaturated fatty acids, and stimulates spermiogenesis and embryo development.
Vitamin F participates in lipid metabolism, promotes the conversion of cholesterol into a soluble form, and increases capillary resistance and blood vessel elasticity.
Indications
Treatment and prevention of A and D3 hypovitaminoses (rickets) in food-producing animals and companion animals, alimentary and secondary osteodystrophy, postpartum hypocalcaemia and hypophosphataemia, pre- and postpartum paresis, alimentary dystrophy, bronchitis and bronchopneumonia, retained placenta, subinvolution of the uterus, endometritis, bone fractures, and joint dysplasia. The product is indicated for diseases associated with impaired absorption and metabolism of vitamins A and D3, calcium and phosphorus (gastroenteritis, hepatodystrophy, hepatitis, ketosis, glomerulonephritis, hypothyroidism, hypoparathyroidism, parakeratosis, Cushing's syndrome).
To ensure full vitamin A supplementation, the product should be administered additionally for prophylactic purposes once every 7 days, and for therapeutic purposes once every 5 days, at the following doses (thousands IU): cows — 300–350 and 350–400, respectively; young cattle (per 100 kg body weight) — 70–80 and 80–90; pregnant mares — 200 and 400; lactating mares — 250 and 550; foals — 50 and 100; pregnant sows — 80 and 150; lactating sows — 120 and 150–200; piglets — 40 and 60–80; pregnant ewes — 25 and 70; lactating ewes — 40 and 80; hens — 6 and 9; geese and turkeys — 15–20 and 30.
Dosage and Administration
The product is administered for prophylactic purposes by intramuscular or subcutaneous injection once every 7 days, for therapeutic purposes by intramuscular injection once every 5 days until recovery (5–8 injections), and thereafter (if necessary) at prophylactic doses.
When using the product, animal diets must be balanced in terms of calcium, phosphorus, and trace elements.
Doses of the product calculated by vitamin D3 content are provided in Table 1.
Table 1
Doses of Triovet-F® calculated based on vitamin D3 content або Dose equivalent of vitamin D3
Contraindications
Hypervitaminosis A, D3, E.
Precautions
Adverse reactions
No adverse reactions have been observed at the recommended doses.
Prolonged use at elevated doses may cause hypervitaminosis.
Use during pregnancy, lactation or lay
In pregnant sows, the product is administered as a single dose 1,5–2 months before farrowing; in pregnant cows — as a single dose 3–4 months before calving.
Presentation
Type I or Type II neutral glass vials (НС-1, НС-2, УСП-1), sealed with rubber stoppers under aluminium crimp caps, with volumes of 10, 20, 50, and 100 ml. Secondary packaging: cardboard box.
Storage
Store in a dry, dark place, out of reach of children, at a temperature of 5 to 25 °C.
Shelf life
18 months.
Shelf life after first withdrawal from the vial: 7 days, provided aseptic withdrawal and subsequent storage at 5 °C.
For veterinary use only!